261
Participants
Start Date
December 31, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Insulin Glargine (Lantus®)
Patient will be randomized to Lantus® while remaining on pre-study oral hypoglycemic agents.
Inhaled Human Insulin (Exubera®)
Patient will be randomized inhaled insulin while remaining on pre-study oral hypoglycemic agents.
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Jessheim
Pfizer Investigational Site, Bornem
Pfizer Investigational Site, Hønefoss
Pfizer Investigational Site, Genk
Pfizer Investigational Site, Liège
Pfizer Investigational Site, Bruderholz
Pfizer Investigational Site, Bergen
Pfizer Investigational Site, Marseille
Pfizer Investigational Site, A Coruña
Pfizer Investigational Site, Lahti
Pfizer Investigational Site, La Rochelle
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Huelva
Pfizer Investigational Site, Besançon
Pfizer Investigational Site, Helsingborg
Pfizer Investigational Site, Málaga
Pfizer Investigational Site, San Cristóbal de La Laguna
Pfizer Investigational Site, Neuss
Pfizer Investigational Site, Gothenburg
Pfizer Investigational Site, Valencia
Pfizer Investigational Site, Alzira
Pfizer Investigational Site, Valenciennes
Pfizer Investigational Site, Kuopio
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Wangen / Allgaeu
Pfizer Investigational Site, Oulu
Pfizer Investigational Site, Corbeil-Essonnes
Pfizer Investigational Site, Eisenach
Pfizer Investigational Site, Altenburg
Pfizer Investigational Site, Hohenmölsen
Pfizer Investigational Site, Leipzig
Pfizer Investigational Site, Riesa
Pfizer Investigational Site, 's-Hertogenbosch
Pfizer Investigational Site, Eindhoven
Pfizer Investigational Site, Nijmegen
Pfizer Investigational Site, The Hague
Pfizer Investigational Site, Venlo
Pfizer Investigational Site, Lysaker
Pfizer Investigational Site, Skedsmokorset
Pfizer Investigational Site, Lodz
Pfizer Investigational Site, Lodz
Pfizer Investigational Site, Lublin
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Łask
Pfizer Investigational Site, Palma de Mallorca
Pfizer Investigational Site, Inca
Pfizer Investigational Site, Borås
Pfizer Investigational Site, Eksjö
Pfizer Investigational Site, Gothenburg
Pfizer Investigational Site, Härnösand
Pfizer Investigational Site, Järfälla
Pfizer Investigational Site, Kristianstad
Pfizer Investigational Site, Linköping
Pfizer Investigational Site, Luleå
Pfizer Investigational Site, Malmo
Pfizer Investigational Site, Motala
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Uddevalla
Pfizer Investigational Site, Umeå
Pfizer Investigational Site, Vaxjo
Pfizer Investigational Site, Sankt Gallen
Lead Sponsor
Pfizer
INDUSTRY